Health authorities in the U.S. are continuing their move away from animal testing in drug development, with the FDA signaling ...
President Donald Trump’s Food and Drug Administration (FDA) is moving to end animal testing practices involving beagles, ...
Non-animal testing methods could save drugmakers time and money, officials say ...
The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as ...
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), a leader in innovative drug development and a vocal advocate for reducing ...
HHS has made reducing animal testing a priority over the past year. In April 2025, the FDA announced it would phase out the ...
The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new ...
March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce ...
Animal models work in lab conditions, because their lives are shorter so you can control the environment in studies.
As the FDA released its draft guidance, the NIH said it will invest $150 million in human-based research to develop the tools ...
The FDA will begin replacing animal testing in the development of monoclonal antibody therapies and other drugs with human-based methods. The agency said the new approach will aim to improve drug ...